Send feedback

CFH p.Arg232Gln

c.695G>A · VCV4291318

Likely pathogenic Single submitter
Classification
Likely pathogenic
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.2108 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 8.5e-05%, nfe)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
2
atypical hemolytic-uremic syndrome

Computational evidence

Protein change
AlphaMissense0.2108likely benign ⚠ discordant with ClinVar
REVEL0.342indeterminate
SaProtLLR -9.81tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 5.8GERP 0.89, phastCons 1
Regional constrainto/e 0.73unconstrained · MANE · 10 kb · p 5.4e-05 · regional, not allelic
Overall
CADD25.2PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.5e-05% European (non-Finnish) · 1/1,176,366 alleles
Overall 0.000137% 2/1,457,186 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.00161% 62,276
European (non-Finnish)grpmax 8.5e-05% 1,176,365

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CFH
Protein
p.Arg232Gln
Coding
c.695G>A
MANE Select
NM_000186
Type
single nucleotide variant
Location
chr1:196679698 (GRCh38)
Gene constraint
LOEUF 0.43 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 78.54 · 51 PDB
Residue 232
a β-strand; a disulfide bond; the sushi 4 domain
Full CFH gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

atypical hemolytic-uremic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: age related macular degeneration 4

For Atypical hemolytic uremic syndrome (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, Not applicable
Onset
All ages
Prevalence
1-9 / 1 000 000 (United States)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cfh-p-arg232gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown